eCOA Solutions: A Cost-Effective Tool for Drug Development

Prevalence of chronic diseases has led to the need for accurate data in clinical trials. Electronic Clinical Outcome Assessment (eCOA) solutions can provide efficient and astute data. This information about patient response can speed up drug & vaccine administration.

eCOA Solutions for Medical Data Collection

Electronic clinical outcome assessment (eCOA) solutions can collect error-free patient data. These methods employ electronic devices such as tablets, personal computers, and smartphones for data collection. They can increase the efficiency of clinical trial data and can speed up drug approval of the regulatory agencies. The eCOA solutions can also predict possibility of future health issues. In addition, they can reduce the reliance on paper and overheads.

Digital Rating Scales

Recently, Bracket Global, a company specializing in clinical research technologies, has signed a pact with the International Parkinson and Movement Disorder Society (MDS). They aim to develop digital versions of rating scales that can monitor progression of Parkinson’s disease (PD). They plan to utilize Unified Dyskinesia Rating Scale (UDysRS) and MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) to obtain accurate data.

Wearable Kits

In 2017, Cognition Kit partnered with Takeda Pharmaceuticals to test capacity of wearables to store clinical data. Their cloud platform, Cambridge Neuropsychological Test Automated Battery (CANTAB), can assist researchers to assess mental & physical health as well as other variables for diverse cognitive assessments.

Market Overview

According to Grand View Research, Inc.; the worldwide electronic clinical outcome assessment (eCOA) solutions market is anticipated to attain USD 2.16 billion by 2025. High adoption by healthcare professionals can impel the market during the forecast period (2014 to 2025). Demand for centralized data storage systems for drug development research and clinical studies can further support market expansion over the years to come.

Web-hosted mode led the overall market on account of revenue share in 2016. Cloud-based mode on the other hand, is expected to gain impressive market shares in the forthcoming years. Its capacity to minimize data theft can propel the adoption. Contract research organizations (CROs) are anticipated to reign as the biggest end-user till 2025. Strong incoming demand from pharmaceutical companies can boost the expansion. Prominent players operating in the global eCOA market are Merge Healthcare Incorporated, CRF Health, BioClinica, and Oracle Corporation.

Read more at:
http://www.grandviewresearch.com/industry-analysis/electronic-clinical-outcome-assessment-ecoa-solutions-market